Virax Biolabs
Business Services · United Kingdom · 11-50 Employees
View Company Info for Free
Overview
Headquarters
Bo'ness Road, Motherwell, North Lanarksh...Phone Number
+442077887414Website
www.viraxbiolabs.comRevenue
<$5 MillionStock Symbol
VRAXIndustry
ZI Rank: 1
Signal Type
Mar
Apr
May
Jun
Jul
Aug
ZI Rank
1
1
1
1
1
1
About Virax Biolabs
Virax Biolabs is a biotechnology company developing T cell-based immune profiling and in vitro diagnostic technologies for viral and immune-mediated diseases. The company provides immunology research assays, laboratory reagents, and diagnostic platforms to support the detection of adaptive immune responses, chronic inflammation, and post-acute infection syndromes such as Long COVID.Explore more
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is Virax Biolabs your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Click to see if Virax Biolabs had a recent Job posting/layoffs
Check out if Virax Biolabs is spiking on competitors!
Congratulate Masked Content for being promoted to Masked Content at Virax Biolabs
Virax Biolabs, which may be a good buyer, showed buying intent in Masked Content Topic
Website visits: Recent activity has been detected on your website
Product Launch: Get notified when Virax Biolabs launches new products
Check if Virax Biolabs has recently received funding, and reach out quickly before it becomes old news!
Funding: Get notified immidiatlly once Virax Biolabs has new funding data
Earning: See what the market has to say on Virax Biolabs recently announced quarterly report
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Recommended Actions
Introduce yourself to Masked Content, who has shown a strong intent to purchase lately
Find 3 more new buyers
Compare Similar Companies to Virax Biolabs
Compare insights from companies similar to Virax Biolabs, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Virax Biolabs
<$5M
11-50
Public
$14.1M
2013
N/A
Company Profile Activity
Activity Insights
Virax Biolabs is experiencing very low activity levels compared to other companies in the Manufacturing sector.
What does this means?
Virax Biolabs is drawing exceptional interest within the Manufacturing industry, suggesting notable developments or strong market momentum, learn more about Virax Biolabs.
Virax Biolabs financials insights
Gather financial insights about Virax Biolabs, including details on funding rounds, investors, total funding, and acquisitions, to gain a comprehensive understanding of their financial strategy.
2022
Stock Offering
$6.8M
2023
Share Placement
$4M
2026
Stock/Share Issuance
$3.3M
Virax Biolabs Tech Stack
A closer look at the technologies used by Virax Biolabs
See more technologies
Most Recent Scoops
Funding
Funding
Project
Product Development, Product Management, Medical Research, Pharmaceuticals, Clinical Operations
New Hire
Executive Move
Lateral Move
Executive Move
Board of Directors
Virax Biolabs News & Media
Virax Biolabs' CEO James Foster Provides Shareholder Update Following Fiscal 2026 Annual Report and Fosun Diagnostics Commercial Supply Agreement
Fiscal 2026 Annual Report, filed July 2, 2026, reflects cash of $6.4 million, total assets of $8.3 million and shareholders' equity attributable to ordinary shareholders of $7.3 million Fosun Diagnostics agreement, announced July 9, 2026, supports commercial execution for ImmuneSelect...Virax Biolabs enters immune profiling product supply deal with Fosun
The collaboration initially focuses on tuberculosis research in Thailand, where Fosun has identified customer interest.Virax Biolabs Group Limited Announces Closing of Exercise of Preferred Investment Options for $3.3 Million Gross Proceeds
LONDON, July 10, 2026 /PRNewswire/ -- Virax Biolabs Group Limited ("Virax" or the "Company") (Nasdaq: VRAX) today closed its previously announced exercise of certain outstanding preferred investment options to purchase up to an aggregate of 548,000 ordinary shares of the Company, par...Virax Biolabs Shares Double After Exclusive Fosun Distribution Agreement (VRAX)
Virax Biolabs Signs Multi-Country Supply PartnershipVirax Biolabs Group Limited (NASDAQ:VRAX) shares surged 100% on Thursday after the company announced an exclusive commercial supply agreement with Fosun Diagnostics for its ImmuneSelect immune profiling product portfolio. The agreement covers six Southeast Asian markets—Thailand, Vietnam, Indonesia, the Philippines, Singapore and Malaysia—and establishes a framework for immediate product shipments through purchase orders, creating new near-term
Read more news
Top Business Services Companies
Top companies in Canada by revenue
Frequently Asked Questions Regarding Virax Biolabs
Sign Up For FreeTo access detailed company insights
Virax Biolabs is a biotechnology company developing T cell-based immune profiling and in vitro diagnostic technologies for viral and immune-mediated diseases. The company provides immunology research assays, laboratory reagents, and diagnostic platforms to support the detection of adaptive immune responses, chronic inflammation, and post-acute infe... Read More
